Treatment response to cenegermin varies by disease stage in neurotrophic keratopathy

Cenegermin is an effective treatment for neurotrophic keratopathy (NK) across disease stages, but recurrence is fairly common, according to a study. This retrospective case series from a single clinical center evaluated 52 eyes from 49 patients. Patients were followed for a mean of 26 months. At baseline, most eyes had...